Photo from wikipedia
This systematic review and meta-analysis examines recent or ongoing nonrandomized clinical trials involving patients with esophageal cancer who received immune checkpoint inhibitors with or without other therapies. Click to show full abstract
This systematic review and meta-analysis examines recent or ongoing nonrandomized clinical trials involving patients with esophageal cancer who received immune checkpoint inhibitors with or without other therapies.
Keywords:
esophageal cancer;
evaluation clinical;
safety outcomes;
outcomes neoadjuvant;
clinical safety;
cancer
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!